Profile | GDS4284 / 1566785_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1373.44 | 79 |
GSM687648 | Patient 402 control | 1924.84 | 83 |
GSM687653 | Patient 403 control | 3146.1 | 89 |
GSM687658 | Patient 404 control | 5478.77 | 94 |
GSM687663 | Patient 411 control | 3859.29 | 91 |
GSM687668 | Patient 422 control | 2734.68 | 88 |
GSM687673 | Patient 424 control | 3288.01 | 90 |
GSM687678 | Patient 425 control | 6235.78 | 95 |
GSM687683 | Patient 427 control | 6188.74 | 95 |
GSM687688 | Patient 428 control | 1368.37 | 79 |
GSM687695 | Patient 441 control | 1748.97 | 83 |
GSM687699 | Patient 443 control | 2646.91 | 88 |
GSM687704 | Patient 444 control | 5157.81 | 93 |
GSM687707 | Patient 448 control | 5950 | 95 |
GSM687712 | Patient 449 control | 2943.28 | 88 |
GSM687719 | Patient 450 control | 4898.46 | 93 |
GSM687724 | Patient 451 control | 5911.24 | 94 |
GSM687728 | Patient 452 control | 2070.67 | 84 |
GSM687646 | Patient 401 treated 24h | 3981.27 | 91 |
GSM687649 | Patient 402 treated 24h | 1367.32 | 78 |
GSM687665 | Patient 411 treated 24h | 3389.27 | 90 |
GSM687651 | Patient 402 treated 4 weeks | 3174.63 | 89 |
GSM687667 | Patient 411 treated 4 weeks | 3048.18 | 89 |
GSM687670 | Patient 422 treated 24h | 2727.35 | 88 |
GSM687671 | Patient 422 treated 4 weeks | 2007.06 | 84 |
GSM687654 | Patient 403 treated 24h | 3889.26 | 91 |
GSM687675 | Patient 424 treated 24h | 2530.7 | 87 |
GSM687685 | Patient 427 treated 24h | 6940.13 | 95 |
GSM687656 | Patient 403 treated 4 weeks | 3316.69 | 90 |
GSM687677 | Patient 424 treated 4 weeks | 3890.12 | 91 |
GSM687687 | Patient 427 treated 4 weeks | 5296.33 | 94 |
GSM687692 | Patient 428 treated 4h | 2711.25 | 87 |
GSM687716 | Patient 449 treated 4h | 5019.57 | 93 |
GSM687722 | Patient 450 treated 4h | 4779.15 | 93 |
GSM687680 | Patient 425 treated 24h | 5293.23 | 94 |
GSM687690 | Patient 428 treated 24h | 1158.85 | 77 |
GSM687700 | Patient 443 treated 24h | 3597.26 | 91 |
GSM687705 | Patient 444 treated 24h | 5105.72 | 93 |
GSM687714 | Patient 449 treated 24h | 3038.66 | 89 |
GSM687721 | Patient 450 treated 24h | 4317.47 | 92 |
GSM687682 | Patient 425 treated 4 weeks | 7724.32 | 96 |
GSM687694 | Patient 428 treated 4 weeks | 3407.95 | 90 |
GSM687702 | Patient 443 treated 4 weeks | 3121.41 | 89 |
GSM687718 | Patient 449 treated 4 weeks | 6036.37 | 95 |
GSM687723 | Patient 450 treated 4 weeks | 3673.37 | 91 |
GSM687661 | Patient 404 treated 4h | 4136.79 | 92 |
GSM687710 | Patient 448 treated 4h | 6930.25 | 95 |
GSM687726 | Patient 451 treated 4h | 6954.65 | 96 |
GSM687730 | Patient 452 treated 4h | 6352.8 | 96 |
GSM687660 | Patient 404 treated 24h | 3697.27 | 91 |
GSM687697 | Patient 441 treated 24h | 1838.25 | 84 |
GSM687709 | Patient 448 treated 24h | 5801.87 | 94 |
GSM687725 | Patient 451 treated 24h | 6267.22 | 95 |
GSM687729 | Patient 452 treated 24h | 3273.31 | 90 |
GSM687727 | Patient 451 treated 4 weeks | 9650.15 | 97 |
GSM687731 | Patient 452 treated 4 weeks | 3242.78 | 90 |